Home > Inhibitors & Agonists

Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4231 Ppxy Budding Inhibitor 5 Specific blocker of the MARV VP40 PPxY-host Nedd4 interaction and subsequent PPxY-dependent egress of MARV VP40 VLPs.
DCC4232 Pqa-11 Novel potent neuroprotectant, inhibiting glutamate-induced cell death, caspase-3 activation, and amyloid β1-42-induced cell death, also suppressing mitogen-activated protein kinase kinase 4 (MKK4) and c-jun N-terminal kinase (JNK) signaling activated by n
DCC4233 Pqc-078 Novel inhibitor of IMPDH enzyme
DCC4234 Pqq-tme Novel human double minute 2 (HDM2) inhibitor
DCC4235 Pqsr Antagonist M64 Quorum sensing modulator as a PqsR antagonist
DCC4236 Pradigastat Featured Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects.
DCC4237 Pravadoline Maleate Inhibitor of prostaglandin (PG) synthesis
DCC4238 Prazosin Inverse agonist at alpha-1 adrenergic receptors
DCC4239 Prexasertib Monolactate Monohydrate Novel inhibitor of checkpoint kinase 1 (CHK1)
DCC4240 Pridopidine Hydrochloride Inducer of Functional Neurorestoration Via the Sigma-1 Receptor
DCC4241 prmt3 Inhibitor 1 Allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)
DCC4242 prmt3 Inhibitor 14u Potent and selective inhibitor of protein arginine methyltransferase 3 (PRMT3)
DCC4243 Prmt4-in-1 Novel potent and selective inhibitor of PRMT4 (also known as CARM1)
DCC4244 Prmt5-in-4b14 Novel potent PRMT5 inhibitor, exhibiting potent anti-proliferative activity against a panel of leukemia and lymphoma cells
DCC4245 Prmt5-in-c17 Featured Novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor
DCC4246 Prmts Inhibitor A36 Potent inhibitor of protein arginine methyltransferases (PRMTs)
DCC4247 Prmts Inhibitor A9 Potent inhibitor of protein arginine methyltransferases (PRMTs)
DCC4248 Prn1008 Novel, Reversible Covalent BTK Inhibitor for Rheumatoid Arthritis
DCC4249 Prn1126 Novel reversible covalent selective LMP7 inhibitor
DCC4250 pr-nhp5g Antagonist at the NR1/NR2A subtype but an agonist at the NR1/NR2D subtype
DCC4251 Probimane Potent inhibitor of tumor metastasis, inhibiting calmodulin, sialic acid, lipoperoxidation, fibrinogen, cell-movement and the cell-cycle arrest
DCC4252 Procaspase-8 Inhibitor 63-r Novel selective procaspase-8 (Pro-C8) Inhibitor covalently binding the zymogen, or inactive precursor (pro-form), of caspase-8, but not other caspases
DCC4253 Pro-nbdhex Prodrug of NBDHEX, selectively inhibiting glutathione transferase (GST P1-1) with better water solubility, and more potent anticancer activities
DCC4254 Protac 14a Novel potent cereblon degrader with DC50 of 200 nM, and 64% protein degradation, as quantified by western blot
DCC4256 Protac Cp17 Novel highly potent degrader against EGFRL858R/T790M and EGFRdel19, reaching the lowest DC 50 values among all reported EGFR-targeting PROTACs
DCC4257 Protac D9a-2 Novel SLC-targeting chimeric degrader, targeting SLC9A1 and other SLC9 family members, effectively impairing pH homeostasis and differentially killing cancer cell lines
DCC4258 Protac Degrader Pp-c8 Novel noncovalent CDK12/13 dual inhibitor, inducing potent and selective CDK12-CycK degradation without affecting CDK13, suppressing DDR-associated genes and induced synthetic lethality with Olaparib
DCC4259 Protac Hl-8 Novel PI3K degrader, showing a significant and complete degradation effect on PI3K kinase at a concentration of 10 μM within 8 h
DCC4260 Protac Nr-7h Novel potent and selective p38α and p38β degrader
DCC4261 Protac P22a Novel degrader of HMGCR protein, potently blocking cholesterol biosynthesis with less compensatory upregulation of HMGCR

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X